⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20371126 | 0.81 | HSD17B10 (0.33) | — | |
| SCHEMBL12750408 | 0.76 | SLC6A4 (0.30) | — | |
| SCHEMBL14037651 | 0.74 | — | — | |
| SCHEMBL18331589 | 0.74 | — | — | |
| SCHEMBL12072033 | 0.74 | — | — | |
| SCHEMBL13696825 | 0.74 | — | — | |
| SCHEMBL13798596 | 0.74 | — | — | |
| SCHEMBL4432747 | 0.73 | — | — | |
| SCHEMBL14012130 | 0.72 | TDP1 (0.35) | — | |
| SCHEMBL10282651 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054766-A2 | MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | MITO BIOPHARMA, LLC (US) | 2024-03-14 | — | — | WO | disclosed |